BA1301 / Luye Group 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BA1301 / Luye Group
CTR20231212: A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of BA1301 for injection in patients with advanced solid tumors

Ongoing
1
China
BA1301 - Luye Group
Shandong Boan Biotechnology Co., Ltd
Advanced solid tumors
 
 

Download Options